TY - JOUR
T1 - Efficacy of Over-the-Counter Moisturizers in Pediatric Atopic Dermatitis
T2 - An Update to a Systematic Review
AU - Osher, Gabrielle Rose
AU - Madkins, Krystal
AU - Lio, Peter
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024
Y1 - 2024
N2 - Introduction: Moisturizers are a mainstay of treatment for atopic dermatitis (AD), a common skin condition affecting children. Pediatric skin is notably different from adult skin, possessing qualities that increase its susceptibility to AD. Care must be taken when choosing the correct emollient for a pediatric AD patient. This review synthesizes the effects of different emollients on various outcome measures in pediatric patients with AD and highlights shortcomings in the literature. Methods: PubMed, EMBASE, and Cochrane Library were indexed, and results were limited to those published after 2015. Randomized controlled trials or controlled clinical studies comparing the effects of an emollient or emollient ingredient against another moisturizer or ingredient, its vehicle, or against no treatment in patients under the age of 18 diagnosed with AD were included. Outcomes measured were clinical outcome data, transepidermal water loss, and stratum corneum hydration. Results: 1348 results were collected, 947 were screened, and 16 were identified as eligible for inclusion. The clinical effect of ceramides is well documented: these products performed better than urea-based formulas and untreated controls, and similarly to paraffin-based formulas in 3 studies. Improvements from glycerin-based products were greater compared to no treatment, and equivalent to other formulas. Two studies comparing emollients of four different vehicle types (lotions, creams, gels, and ointments) found comparable effectiveness among them. Conclusion: Compared to no treatment, moisturizers of any type effectively improve symptoms and skin conditions seen in children with AD. However, due to heterogeneity in protocols, products, and outcome measures across the studies, few widespread conclusions could be drawn. Further investigation into emollient formulations for pediatric AD is warranted to provide reliable information that is applicable in clinical settings.
AB - Introduction: Moisturizers are a mainstay of treatment for atopic dermatitis (AD), a common skin condition affecting children. Pediatric skin is notably different from adult skin, possessing qualities that increase its susceptibility to AD. Care must be taken when choosing the correct emollient for a pediatric AD patient. This review synthesizes the effects of different emollients on various outcome measures in pediatric patients with AD and highlights shortcomings in the literature. Methods: PubMed, EMBASE, and Cochrane Library were indexed, and results were limited to those published after 2015. Randomized controlled trials or controlled clinical studies comparing the effects of an emollient or emollient ingredient against another moisturizer or ingredient, its vehicle, or against no treatment in patients under the age of 18 diagnosed with AD were included. Outcomes measured were clinical outcome data, transepidermal water loss, and stratum corneum hydration. Results: 1348 results were collected, 947 were screened, and 16 were identified as eligible for inclusion. The clinical effect of ceramides is well documented: these products performed better than urea-based formulas and untreated controls, and similarly to paraffin-based formulas in 3 studies. Improvements from glycerin-based products were greater compared to no treatment, and equivalent to other formulas. Two studies comparing emollients of four different vehicle types (lotions, creams, gels, and ointments) found comparable effectiveness among them. Conclusion: Compared to no treatment, moisturizers of any type effectively improve symptoms and skin conditions seen in children with AD. However, due to heterogeneity in protocols, products, and outcome measures across the studies, few widespread conclusions could be drawn. Further investigation into emollient formulations for pediatric AD is warranted to provide reliable information that is applicable in clinical settings.
KW - Atopic dermatitis
KW - Emollient
KW - Moisturizer
KW - Pediatrics
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85204792139&partnerID=8YFLogxK
U2 - 10.1007/s13671-024-00453-9
DO - 10.1007/s13671-024-00453-9
M3 - Review article
AN - SCOPUS:85204792139
SN - 2162-4933
JO - Current Dermatology Reports
JF - Current Dermatology Reports
ER -